Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label Phase 2 Study of MDMA-Assisted Psychotherapy in Veterans With Combat-Related, Refractory PTSD

NCT04264026 is registered in ClinicalTrials.gov with VA Loma Linda Health Care System as lead sponsor.

NCT NCT04264026
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04264026 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label Phase 2 Study of MDMA-Assisted Psychotherapy in Veterans With Combat-Related, Refractory PTSD
Lead sponsor
VA Loma Linda Health Care System
Phase
Phase 2
Overall status
Completed
Start date
July 29, 2021
Completion date
May 1, 2025
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

combat stress disorders, post traumatic stress disorder